Order of the President of the Court of First Instance of 24 April 2009. – Nycomed Danmark ApS v Agence européenne des médicaments (EMEA).

Subject of the case

Re:

APPLICATION, first, for suspension of the operation of the EMEA’s decision of 28 November 2008 rejecting the application for a product-specific waiver concerning perflubutane and, secondly, for the grant of interim measures.

Operative part

Operative part

1. The application for interim measures is dismissed.

2. Costs are reserved.